News
-
-
PRESS RELEASE
FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. (NASDAQ:JAGX) receives FDA renewal for Canalevia-CA1, a prescription drug for chemotherapy-induced diarrhea (CID) in dogs, with conditional approval extended until December 2026 -
PRESS RELEASE
The Platform Group AG successfully completes planned portfolio disposal
The Platform Group AG completes planned portfolio disposal of three non-core assets, Emco Electroroller, Aplanta, and X-Mobility, contributing 0.2% of revenue. Company aims to focus on larger shareholdings for increased margins -
PRESS RELEASE
DataMetrex Signs Definitive Agreement to Acquire Yuzu Payment Processing Solution From Firstpayment Inc.
Datametrex AI Limited announces acquisition of Yuzu payment processing solution from Firstpayment Inc. through a definitive asset purchase agreement. Transaction expected to close on December 17, 2025 -
-
-
-
-
PRESS RELEASE
Netfonds Group continues dynamic growth in the first nine months of 2025
Netfonds Group reports dynamic growth in the first nine months of 2025, with significant increases in EBITDA and EBITDA margin. All business units show growth, with a focus on efficiency and scaling up. Management confirms positive forecast for the year -
PRESS RELEASE
Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics
Indivumed partners with University of Rochester Medical Center for patient-centric cancer therapeutics discovery, focusing on precision oncology and advanced stages of solid cancers
